Innospec Inc. $IOSP Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP lessened its position in shares of Innospec Inc. (NASDAQ:IOSP) by 38.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 17,422 shares of the specialty chemicals company’s stock after selling 10,852 shares during the period. GSA Capital Partners LLP’s holdings in Innospec were worth $1,333,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC raised its stake in shares of Innospec by 1,159.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after buying an additional 487 shares during the last quarter. Allworth Financial LP raised its stake in Innospec by 31.0% in the 3rd quarter. Allworth Financial LP now owns 588 shares of the specialty chemicals company’s stock valued at $45,000 after purchasing an additional 139 shares during the last quarter. Danske Bank A S acquired a new position in Innospec in the 3rd quarter valued at about $46,000. State of Wyoming raised its stake in Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after purchasing an additional 173 shares during the last quarter. Finally, Signaturefd LLC raised its stake in Innospec by 65.5% in the 4th quarter. Signaturefd LLC now owns 993 shares of the specialty chemicals company’s stock valued at $76,000 after purchasing an additional 393 shares during the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Trading Up 2.3%

Shares of IOSP stock opened at $78.66 on Thursday. The firm has a 50-day moving average price of $74.32 and a 200 day moving average price of $76.87. Innospec Inc. has a twelve month low of $65.51 and a twelve month high of $92.14. The company has a market capitalization of $1.94 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 2.14 and a beta of 0.90.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Friday, May 8th. The specialty chemicals company reported $1.05 EPS for the quarter, beating the consensus estimate of $1.02 by $0.03. The company had revenue of $453.20 million during the quarter, compared to analysts’ expectations of $432.14 million. Innospec had a return on equity of 9.32% and a net margin of 6.38%.The firm’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.42 EPS. As a group, research analysts predict that Innospec Inc. will post 4.8 earnings per share for the current year.

Innospec Dividend Announcement

The firm also recently declared a dividend, which will be paid on Friday, May 29th. Shareholders of record on Tuesday, May 19th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, May 19th. This represents a yield of 239.0%. Innospec’s payout ratio is 40.09%.

Analyst Ratings Changes

IOSP has been the subject of several analyst reports. Wall Street Zen downgraded shares of Innospec from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings downgraded shares of Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, May 11th. Finally, Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a research note on Friday, April 24th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce”.

Insiders Place Their Bets

In other Innospec news, Director David Landless sold 594 shares of Innospec stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the sale, the director owned 7,632 shares in the company, valued at $584,305.92. The trade was a 7.22% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Larry Padfield sold 594 shares of Innospec stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the sale, the director owned 9,453 shares of the company’s stock, valued at $723,721.68. This trade represents a 5.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 4,989 shares of company stock worth $391,889 over the last 90 days. Corporate insiders own 1.45% of the company’s stock.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.